Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Elevated Triglycerides (Hypertriglyceridemia) Clinical Trials

A listing of Elevated Triglycerides (Hypertriglyceridemia) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (11) clinical trials

This study will compare pemafibrate (K-877) compared to placebo to discover if pemafibrate lowers cardiovascular complications such as heart attack, stroke, and death from these conditions in adults with Type II Diabetes mellitus who have elevated triglycerides and low high-density lipoprotein cholesterol (HDL-C "good cholesterol). The study will also test ...

Phase

Don't wait, participate! A clinical trial for high triglycerides is now enrolling in Gurnee, Illinois. Play an active role in your health care and contact us to see if you qualify to participate.

Phase

Don't wait, participate! A clinical trial for people with type 2 diabetes, who also have high triglycerides and low, good cholesterol is now enrolling.  Play an active role in your health care and contact us to see if you qualify to participate in this study.

Phase

Don't wait, participate! A clinical trial for type 2 diabetes with high triglycerides is now enrolling. Play an active role in your health care and contact us to see if you qualify to participate in this study.

Phase

The purpose of this study is to determine whether CaPre® 4g daily can help lower fasting triglyceride (a kind of fat in the blood) levels. The safety and tolerability of CaPre® will also be assessed. In addition, this study will compare CaPre® 4g daily with placebo, a substance that looks like ...

Phase

A clinical research study is underway for those who have been diagnosed with Type 2 diabetes, have high Triglycerides, low HDL cholesterol “good cholesterol”, and are at risk for future cardiovascular events. The main goal of this study is to learn, if a potential new medication can help prevent heart ...

Phase

To determine the efficacy of CaPre 4 g daily, compared to placebo, in lowering fasting triglyceride (TG) levels in patients with fasting TG levels ≥500 mg/dL and ≤1500 mg/dL (≥5.7 mmol/L and ≤17.0 mmol/L) after 12 weeks of treatment.

Phase

Do you have hypertriglyceridemia? 

Phase

A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)

The primary objective of this study is to determine the efficacy of CaPre 4 g daily, compared to placebo, in lowering fasting triglyceride (TG) levels in patients with fasting TG levels 500 mg/dL and 1500 mg/dL (5.7 mmol/L and 17.0 mmol/L) after 12 weeks of treatment. Approximately 615 subjects will ...

Phase